Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran.

1Roshanak Mehdipour Dastjerdi, 1Fereshteh Ashtari 1Isfahan University of Medical Sciences, Isfahan, Iran; 2Isfahan Neurosciences Research Center, Isfahan, Iran Background: The knowledge about gender based different characteristics of multiple sclerosis (MS) is important to find new strategies for further managing and treatment. On the other hand patientˈs sex can be an important risk factor for incidence…

A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece

1Christos Bakirtzis, 1Marina – Kleopatra Boziki, 1Eleni Grigoriadou, 1Evangelia Kesidou, 1Ioannis Nikolaidis, 1Styliani-Aggeliki Sintila, 2Theodoros Moysiadis, 2Dimitra Tsakona, 3Georgios Papazisis, 1Nikolaos Grigoriadis 1Multiple Sclerosis Center, B’ Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece; 2Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece; 3Department of Clinical Pharmacology, Aristotle University of Thessaloniki,…

Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia.

1A. Al Harbi, 1S.Al Mohaisen, 1A.Alotaibi, 1A.Alrumaih, 1I. Ali Alghamdi, 1G.Alghamdi, 1M. Almuhanna 1King Abdullah Bin Abdul-Aziz University Hospital, Riyadh, Saudi Arabia Background: Exploring the prevalence of lower urinary tract symptoms (LUTS) in multiple sclerosis (MS) patients may lead to optimizing therapeutic interventions that could improve their quality of life (QoL). The main objective of…

Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region

1Murad Al-Naqshbandi, 1Hoda Joudi, 1Abed Raki 1Merck Serono Middle East FZ-Ltd (an affiliate of Merck KGaA), Dubai, United Arab Emirates Background/Objective(s): Several factors rendered patients with multiple sclerosis (pwMS) likely to be affected by the rapidly evolving events of the COVID-19 pandemic. Globally, pwMS were confronted with limited access to their healthcare team, potential treatment…

Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden

1Meritxell Sabidó Espin, 2Kiliana Suzart-Woischnik, 3Nydjie Grimes, 4Lisa M Prach, 5Liwei Zhao, 5Katja M Hakkarainen 1Merck Healthcare KGaA, Darmstadt, Germany; 2Bayer AG, Berlin, Germany; 3Biogen Netherlands B.V., Badhoevedorp, Netherlands; 4Novartis Pharma AG, Basel, Switzerland; 5Global Database Studies (GloDaSt), Gothenburg, Sweden Background/Objective(s): Previous studies showed no increased risk of interferon beta use before or early in…

Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco.

1Rachid Lotfi, 1Fatiha Chigr, 1Mohamed Najimi 1Faculty of Sciences and Techniques, Beni Mellal, Morocco Objective(s): To analyze the socio-demographic characteristics of patients with multiple sclerosis disease in Morocco. Material(s) and Method(s): This study concerned a sample made up of 420 patients or 6% of the total population estimated by “Atlas of MS”, representing 7 regions…

Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience

1Ahmed Essmat 1Al Azhar University, Cairo, Egypt Background: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a challenge for all participants in the healthcare system. At the beginning of the pandemic, many doctors asked themselves how to manage patients with multiple sclerosis(MS).we had followed 87 patient with MS(Al- azhar university MS clinic, cairo,Egypt). With…

Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman

2Abdullah Al-Asmi, 1Salma Al-Abri, 2Arunodaya R. Gujjar, 2Ahmed Al-Qassabi, 2Haifa Al-Abri 1Internal Medicine Residency Program, Oman Medical Specialty Board (OMSB), Muscat, Oman; 2Neurology Division, Medicine Department, College of Medicine and Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman Background/Objective(s): Multiple sclerosis (MS) is an immune mediated central nervous system demyelinating disorder…

Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS

1Nahid Beladi Moghadam, 1Mahran Ghaffari, 2Saba Sadeghi Rashed, 1Tannaz Fazli, 1Omid Hesami 1Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Islamic Azad University Central Tehran Branch, Tehran, Iran Introduction: Patients with benign multiple sclerosis (BMS) represent 10–20% of patients with MS, and are characterized by accumulation of modest or no disability over a long period…

Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort

1,2Imen Kacem, 1,2Saloua Mrabet, 1,2Amira Souissi, 1,2Alya Gharbi, 1,2Lilia Hmissi, 1,2Firas Larnaout, 1,2Amina Gargouri, 1,2Riadh Gouider 1Razi University Hospital, Manouba, Tunisia; 2Faculty of medicine, University Tunis El Manar, Tunis, Tunisia Background: Multiple sclerosis (MS) is universally reported to be more prevalent in women than men. In Tunisia, gender ratio (women/men) has markedly increased in Tunisian…